These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25028623)

  • 1. Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?
    Jager KJ; Lindholm B; Goldsmith D; Fliser D; Wiecek A; Suleymanlar G; Ortiz A; Massy Z; Martinez-Castelao A; Agarwal R; Blankestijn PJ; Covic A; London G; Zoccali C; Dekker FW;
    Kidney Int Suppl (2011); 2011 Jun; 1(1):21-23. PubMed ID: 25028623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.
    Vogelzang JL; van Stralen KJ; Noordzij M; Diez JA; Carrero JJ; Couchoud C; Dekker FW; Finne P; Fouque D; Heaf JG; Hoitsma A; Leivestad T; de Meester J; Metcalfe W; Palsson R; Postorino M; Ravani P; Vanholder R; Wallner M; Wanner C; Groothoff JW; Jager KJ
    Nephrol Dial Transplant; 2015 Jun; 30(6):1028-37. PubMed ID: 25637641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and noncardiovascular mortality among patients starting dialysis.
    de Jager DJ; Grootendorst DC; Jager KJ; van Dijk PC; Tomas LM; Ansell D; Collart F; Finne P; Heaf JG; De Meester J; Wetzels JF; Rosendaal FR; Dekker FW
    JAMA; 2009 Oct; 302(16):1782-9. PubMed ID: 19861670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study.
    Strippoli GF; Palmer SC; Ruospo M; Natale P; Saglimbene V; Craig JC; Pellegrini F; Petruzzi M; De Benedittis M; Ford P; Johnson DW; Celia E; Gelfman R; Leal MR; Torok M; Stroumza P; Bednarek-Skublewska A; Dulawa J; Frantzen L; Ferrari JN; del Castillo D; Hegbrant J; Wollheim C; Gargano L;
    BMC Nephrol; 2013 Apr; 14():90. PubMed ID: 23597063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-Dialysis Visits to a Nephrology Department and Major Cardiovascular Events in Patients Undergoing Dialysis.
    Huang CY; Hsu CW; Chuang CR; Lee CC
    PLoS One; 2016; 11(2):e0147508. PubMed ID: 26900915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of early nephrology referral on mortality and hospitalization in peritoneal dialysis patients.
    Chow KM; Szeto CC; Law MC; Kwan BC; Leung CB; Li PK
    Perit Dial Int; 2008; 28(4):371-6. PubMed ID: 18556379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
    Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Nephrology Referral 6 Months Before Dialysis Initiation Can Reduce Early Death But Does Not Improve Long-Term Cardiovascular Outcome on Dialysis.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Nagayama H; Ohno M; Uematsu K; Tamai T; Nishide T; Rakugi H; Isaka Y
    Circ J; 2016; 80(4):1008-16. PubMed ID: 26876973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Early Predialysis Nephrology Care and Postdialysis Cardiovascular Events.
    Yang JY; Huang JW; Chen L; Chen YY; Pai MF; Tung KT; Peng YS; Hung KY
    Am J Kidney Dis; 2017 Aug; 70(2):164-172. PubMed ID: 28262267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy.
    den Hoedt CH; Bots ML; Grooteman MP; Mazairac AH; Penne EL; van der Weerd NC; Ter Wee PM; Nubé MJ; Levesque R; Blankestijn PJ; van den Dorpel MA;
    PLoS One; 2013; 8(4):e61155. PubMed ID: 23620729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality risk in European children with end-stage renal disease on dialysis.
    Chesnaye NC; Schaefer F; Groothoff JW; Bonthuis M; Reusz G; Heaf JG; Lewis M; Maurer E; Paripović D; Zagozdzon I; van Stralen KJ; Jager KJ
    Kidney Int; 2016 Jun; 89(6):1355-62. PubMed ID: 27165828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure.
    Obrador GT; Pereira BJ
    Am J Kidney Dis; 1998 Mar; 31(3):398-417. PubMed ID: 9506677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].
    Jungers P; Joly D; Nguyen-Khoa T; Mothu N; Bassilios N; Grünfeld JP
    Presse Med; 2006 Jan; 35(1 Pt 1):17-22. PubMed ID: 16462659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.
    Swai J; Zhao X; Noube JR; Ming G
    BMC Nephrol; 2020 May; 21(1):156. PubMed ID: 32357924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidative vitamines for prevention of cardiovascular disease for patients after renal transplantation and patients with chronic renal failure.
    Schnell-Inderst P; Kossmann B; Fischereder M; Klauss V; Wasem J
    GMS Health Technol Assess; 2006 Jul; 2():Doc14. PubMed ID: 21289965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of predialysis nephrological care and mortality after dialysis initiation.
    Iwata Y; Okushima H; Takatsuka T; Yoshimura D; Kawamura T; Iio R; Ueda Y; Shoji T; Hayashi T; Isaka Y
    Clin Exp Nephrol; 2020 Aug; 24(8):705-714. PubMed ID: 32281008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
    Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
    Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants.
    Barylski M; Nikfar S; Mikhailidis DP; Toth PP; Salari P; Ray KK; Pencina MJ; Rizzo M; Rysz J; Abdollahi M; Nicholls SJ; Banach M;
    Pharmacol Res; 2013 Jun; 72():35-44. PubMed ID: 23542730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.